Recombinant Human Interleukin 7 Receptor, Fc Chimera
Cat.No. : | IL7R-129H |
Product Overview : | Recombinant Human interleukin 7 receptor the signal peptide and extracellular domain of human Interleukin 7 receptor alpha chain (IL-7Ra)(aa 1-236) was expressed in modifiedhuman 293 cells. It was fused to the Fc region of human IgG1 (aa 93-330). |
- Specification
- Gene Information
- Related Products
Cat. No. : | IL7R-129H |
Description : | Interleukin 7 (IL-7) is a cytokine that is essential for lymphopoiesis as well as T cell homeostasis and the maintenance of T cell diversity. Additionally, IL-7 promotes T cell cytolytic responses, and acts as co-stimulator for the activation of mature B cells. |
Source : | Human 293 cells. |
Amino Acid Sequence : | ESGYAQNGDLE DAELDDYSFS CYSQLEVNGSQ HSLTCAFEDP DVNITNLEFE ICGALV EV KCL NFRKLQ EIY FIETKKF LLIGKSNIC VKVGEKSLTC KKI DLTTI VKPEA PFDLSVVYREGA NDFVVTFNTSH LQKKYVKVLM HDVAYRQEK DE NKWTHVN LSSTKLTLLQRK LQPAA MYE IKVRS IPDHYFKGF WSEWSPSY YFRT PEINNSSG GIPKVDKKVEPKS CDKTHTCPPCPAPE LLGGPSVFLFPPKPK DTLM ISRTPEVT CVVVDVSHEDPEVK FNWYVDGVEVHNA KTKPR E E QY NSTYRVV SVLTV LHQDWLNGKEY KCRVSNKALPAPIEK TISKAKGQPREPQVYT LPP SRDE LTKNQVSLTCL VKGFYPSDIAVEWESNG QPENNYKTTP PVLDSD GSFFLY SKLTV DKSR WQQGNVFSCSVMHEALHNHYTQKSLSLSPGK. |
Molecular Mass : | IL-7R alpha-Fc Chimera migrates as a broad band between 75 and 90 kDa in SDS-PAGE due to post-translation modifications, in particular glycosylation. This compares with the unmodified IL-7 R alpha-Fc Chimera that has a predicted molecular mass of 50.0kDa. |
PI : | IL-7 R alpha-Fc Chimera separates into a number of isoforms with a pI between 5.9 and 7.4 in 2D PAGE due to post-translational modifications, in particular glycosylation. This compares with the unmodified IL-7R alpha-Fc Chimera that has a predicted pI of 6.34. |
% Carbohydrate : | Purified IL-7R alpha-Fc Chimeraconsists of 30-45% carbohydrate by weight. |
Glycosylation : | IL-7R alpha-Fc Chimera is N-glycosylated and may be O-glycosylated. |
Purity : | >95%, as determined by SDS-PAGE and visualized by silver stain. |
Formulation : | When reconstituted in 0.5 ml sterile phosphate-buffered saline, the solution will contain 1% human serum albumin (HSA) and 10% trehalose. |
Reconstitution : | It is recommended that 0.5 ml of sterile phosphate-buffered saline be added to the vial. |
Storage : | Lyophilized products should be stored at 2 to 8°C. Following reconstitution short-term storage at 4°C is recommended, and longer-term storage of aliquots at -18 to -20°C. Repeated freeze thawing is not recommended. |
Gene Name : | IL7R interleukin 7 receptor [ Homo sapiens ] |
Synonyms : | IL7R; interleukin 7 receptor; CD127; CDW127; IL-7R-alpha; IL7RA;ILRA; CD127 antigen; interleukin 7 receptor alpha chain; interleukin 7 receptor isoform H5-6; CDw127 |
Gene ID : | 3575 |
mRNA Refseq : | NM_002185 |
Protein Refseq : | NP_002176 |
MIM : | 146661 |
UniProt ID : | P16871 |
Chromosome Location : | 5p13 |
Pathway : | Cytokine-cytokine receptor interaction; Jak-STAT signaling pathway; Hematopoietic cell lineage; Primary immunodeficiency |
Function : | interleukin-7 receptor activity; protein binding; antigen binding; receptor activity |
Products Types
◆ Recombinant Protein | ||
IL7R-2260H | Recombinant Human IL7R protein (Glu21-Gly236), His-tagged | +Inquiry |
IL7R-0305H | Active Recombinant Human IL7R protein(Met1-Gly236), hFc-tagged | +Inquiry |
IL7R-2179H | Recombinant Human IL7R Protein, MYC/DDK-tagged | +Inquiry |
IL7R-1361H | Recombinant Human IL7R protein(Met1-Gly236), His&Avi-tagged, Biotinylated | +Inquiry |
IL7R-5168H | Recombinant Human IL7R Protein, GST-tagged | +Inquiry |
◆ Lysates | ||
IL7R-2473MCL | Recombinant Mouse IL7R cell lysate | +Inquiry |
IL7R-959RCL | Recombinant Rat IL7R cell lysate | +Inquiry |
IL7R-2595HCL | Recombinant Human IL7R cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionIL7R is a potential drug for tumor immunotherapy, which is expected to enhance anti-tumor immune response, but further research and clinical demonstration are still needed.
Recombinant IL7R can enhance the body's immune response, but there is not enough evidence to show that it can be used to treat immune system failure.
It can enhance the immune response ability of T cells and improve the immune response of the body, so as to have a therapeutic effect on immune-related diseases.
There is no clear evidence that IL7R has a synergistic effect with immune checkpoint inhibitors, but this research direction deserves further exploration.
IL7R has been associated with immune-related diseases such as cancer, inflammatory bowel disease, and rheumatoid arthritis.
The use of IL7R is patient specific and may be subject to some limitations, such as pregnant and lactating women and patients with certain immune-related diseases.
Customer Reviews (3)
Write a reviewThe pharmacodynamic parameters of IL7R were good.
IL7R has good compatibility and stability with various excipients.
Strong potential to desensitize specific allergens.
Ask a Question for All IL7R Products
Required fields are marked with *
My Review for All IL7R Products
Required fields are marked with *
Inquiry Basket